Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Competitive analysis, business development and manufacturing intelligence tool aids complex decision making for CDMOs
Evaluate will be the exclusive reseller of HealthTech Alpha across the globe
New capabilities greatly enhance Evaluate’s Competitive Intelligence Practice by combining best-in-class R&D, clinical and commercialisation intelligence with expert…
Competitive analysis, business development and manufacturing intelligence tool aids complex decision making for CDMOs
Evaluate will be the exclusive reseller of HealthTech Alpha across the globe
New capabilities greatly enhance Evaluate’s Competitive Intelligence Practice by combining best-in-class R&D, clinical and commercialisation intelligence with expert…
New World Preview report shows healthy near-term growth trajectory despite Pharma’s Age of Uncertainty
The Solactive Evaluate Global Pharma Index is a representation of securities with potential future revenues in the pharmaceutical industry.
Prestigious International Annual Awards Programme Honours Standout AI and Machine Learning Solutions and Companies
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
New World Preview report finds strong top-line growth as pricing and patent headwinds build
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
東京、日本-2022年5月26日 – 製薬業界における戦略策定や事業性評価に不可欠な信頼性の高いマーケット情報及び分析を提供するEvaluate(エバリュエート本社:ロンドン)は、2022年4月に発行した希少疾病用医薬品動向レポート 「オーファンドラッグ 2022 レポート」(原文:英語)の日本語版をリリースしました。
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].